Marvin Fojtasek MD in Rowlett, Texas

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Texas Medical Branch At Galveston
Graduation Year: 1981
The Primary Medical Specialty for Marvin Fojtasek MD is listed as: Infectious Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 43
PAC (PECOS ID)#: 1456453455
NPI #: 1669475737
NPI Created On: 05/23/2005
NPI Last Updated Listed as: 04/19/2018
Primary Taxonomy Code: 207RI0200X
License Number:
F9429
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Molina Marketplace
• Celtic Insurance Company
• Humana
• Oscar Insurance Company
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Insertion of central venous catheter for infusion using imaging guidance, patient 5 years or older
3. Collection of blood specimen from central or peripheral venous catheter
4. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
5. Infusion into a vein for therapy, prevention, or diagnosis
6. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
7. Injection of drug or substance into a vein for therapy, diagnosis, or prevention
8. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
9. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
10. Infusion of chemotherapy into a vein up to 1 hour
11. Infusion of chemotherapy into a vein
12. Established patient office or other outpatient visit, typically 5 minutes
13. Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
14. Injection, daptomycin, 1 mg
15. Injection, denosumab, 1 mg
16. Injection, ertapenem sodium, 500 mg
17. Injection, infliximab, excludes biosimilar, 10 mg
18. Injection, mepolizumab, 1 mg
19. Injection, omalizumab, 5 mg
20. Injection, methylprednisolone sodium succinate, up to 125 mg